Q3 is the past now....Q4 is where we as investors need to start focusing on.
CPG took their impairment charge early ( usually taken in Q4) so I dont think that will be repeated in Q4 putting a drag on earnings.
Price of oil on avg $5 or more higher than Q3. Impact +100M to topline. If oil climbs and ends this year at $55 that will pull the avg up more with greater impact to top line.
The January Effect. Institutions/Funds in the US start buying names that they feel will grow. Especially if they have had a name like CPG on their books and sold for tax loss the year before.
The story is Q4 and 2018...I see this as a turning point in CPG.
Cheers